Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

In furtherance to our earlier intimation dated March 21, 2024, Re. Incorporation of Section 8 Company (Non-profit Organization), we would like to inform you that Section 8 Company, Global Health Institute of Medical Sciences Foundation, Wholly-owned Subsidiary has been incorporated on March 30, 2024.
30-03-2024
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Allotment of Equity Shares, pursuant to exercise of ESOPs under GHL - Employees Stock option Scheme 2016 (ESOP 2016 Scheme)
23-03-2024
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Acquisition

The Board at its meeting today, has approved the Incorporation of Section 8 Company, by subscribing 100% Equity Share Capital of the said Proposed Company.
21-03-2024
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Restructuring

The Board in its meeting held today, has approved the scheme of Amalgamation between the Company and Medanta Holdings Private Limited, wholly-owned subsidiary of the Company.
21-03-2024
Bigul

Global Health Ltd - 543654 - Closure of Trading Window

Closure of Trading Window for the Q4 and Financial Year ending March 31, 2024
16-03-2024
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that representatives of the following Investors/Analysts are scheduled to meet the Management of the Company, as per schedule attached.
12-03-2024
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that representatives of the following Investors/Analysts are scheduled to meet the Management of the Company, as per schedule attached.
12-03-2024
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that representatives of the following Investors/Analysts are scheduled to meet the Management of the Company, as per schedule attached.
06-03-2024
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that representatives of the following Investors/Analysts are scheduled to meet the Management of the Company, as per schedule attached.
06-03-2024
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that representatives of the Macquarie Capital (Investor) are scheduled to meet with the Management of the Company, as per schedule attached.
04-03-2024
Next Page
Close

Let's Open Free Demat Account